News | Lumen Bioscience

10/5/2021	Lumen Bioscience Awarded Federal Funding to Advance Covid-19 Antibody Cocktail through Phase 2 Clinical Evaluation
8/31/2021	Lumen Bioscience Launches Phase 1 Trial of Oral Biologic Drug for Preventing C. difficile Infection Recurrence
8/10/2021	Lumen Bioscience Teams with Google to Apply Machine Learning to Biologics Manufacturing
7/12/2021	Lumen Bioscience Expands Biologics Manufacturing Capacity with Lease of Historic Seattle Bakery
6/16/2021	Lumen Bioscience and Novo Nordisk Enter into Research Collaboration to Explore Novel Strategies to Deliver Oral Biologics for Cardiometabolic Disease
4/21/2021	Lumen Bioscience Announces Appointment of Marcos Milla, Ph.D. to Board of Directors & Expansion of Leadership Team